A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian).

Source:http://linkedlifedata.com/resource/pubmed/id/15948013

Download in:

View as

General Info

PMID
15948013